Host Mike Moore interviews Co-Founder & Chief Medical Officer, Dr. Randy Moore of ViTAA Medical. ViTAA's AI-backed SaMD offers precision, personalized medicine to non-invasively map the strength and weakness of abdominal aortic aneurysms (AAA). ViTAA’s RAW™ (Regional Areas of Weakness) Map technology can analyze the deformation of the aorta wall using images captured throughout the cardiac cycle. Then, by incorporating critical simulation data on blood flow and the location and size of clots (ILT or intraluminal thrombus) within the aneurysm, ViTAA’s algorithms compute and generate detailed vulnerability maps of the abdominal aortic aneurysm. The technology is available as part of the ViTAA Registry, which has been launched in 8 North American sites. Further access to the technology will also be possible through ViTAA’s Research Use Only Program, which was initiated in late 2022.Resources & LinksLinkedIn: Mike MooreLinkedIn: The Bleeding Edge of Digital Health

Ver todos los episodios